Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
9 Results for "
fungal hyphal growth
" in MedChemExpress (MCE) Product Catalog:
Products (9)
9 Results for "fungal hyphal growth" in MCE Product Catalog:
1
Quinalizarin is a protein kinase CK2 inhibitor with a Ki of 0.052 μM. Quinalizarin exhibits antifungal and anticancer activities. Quinalizarin induces ROS production, apoptotic signaling, mitochondrial pathway activation, cell cycle arrest, and cytotoxicity in cancer cells. Quinalizarin inhibits hyphal growth, biofilm formation, and mature biofilm integrity of Candida albicans. Quinalizarin can be used in research related to cancer and fungal infections .
Cat. No.: HY-N2558
CAS No.: 19668-69-0
Category:
Murraya paniculata (L.) Jack. Rutaceae Coumarins Phenylpropanoids Plants Disease Research Fields Cancer
Target:
Cat. No.: HY-N7435R
CAS No.: 54814-64-1
Synonyms: (±)-Massoia lactone (Standard)
Category:
Cat. No.: HY-189257
CAS No.: 848488-07-3
Antifungal agent 178 is an indole-oxazole alkaloid analog and a fungal cell membrane disruptor that exhibits low phytotoxicity toward plants. Antifungal agent 178 disrupts the integrity of hyphal cell membranes, leading to cytoplasmic leakage and inhibition of hyphal growth, and induces morphological changes in hyphae. Antifungal agent 178 can be used in research related to fungal plant diseases .
Cat. No.: HY-N19791
CAS No.: 13410-15-6
Category:
Monophenols Coumarins Phenols Decachaeta ovatifolia (DC.) R.M.King & H.Rob. Phenylpropanoids Plants Umbelliferae
Target:
Cat. No.: HY-181346
CAS No.: 3103433-67-3
Target:
Research Areas:
SDH-IN-44 is a succinate dehydrogenase (SDH) inhibitor with an IC50 of 12.5 μg/mL against Alternaria solani. SDH-IN-44 exhibits antifungal activity and inhibits fungal mycelial growth. SDH-IN-44 is applicable to research related to fungal infections .
Cat. No.: HY-187509
Target:
Research Areas:
Succinate dehydrogenase-IN-13 is a succinate dehydrogenase inhibitor with an IC50 of 8.69 μM against Rhizoctonia solani. Succinate dehydrogenase-IN-13 binds stably within the succinate dehydrogenase active site to disrupt fungal respiration and energy metabolism, and induces hyphal distortion and mitochondrial damage in Rhizoctonia solani. Succinate dehydrogenase-IN-13 reduces intracellular ATP levels in Rhizoctonia solani mycelia. Succinate dehydrogenase-IN-13 can be used for the research of Rhizoctonia solani infection, Botrytis cinerea infection .
Cat. No.: HY-181610
CAS No.: 3112883-32-3
Target:
Research Areas:
SDH-IN-45 is a succinate dehydrogenase BcSDH inhibitor and mycelial growth inhibitor targeting Botrytis cinerea, with an IC50 of 5.97 μg/mL against Botrytis cinerea. SDH-IN-45 inhibits succinate dehydrogenase, a component of the mitochondrial electron transport chain, via a unique binding mode, thereby regulating fungal energy metabolism. SDH-IN-45 causes morphological damage to Botrytis cinerea mycelia, leading to collapse and shrinkage of mycelial structures. SDH-IN-45 exhibits in vitro fungicidal activity against Botrytis cinerea. SDH-IN-45 can be used in research related to cucumber gray mold .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
